Clinical Trial Update: METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating METR-NK cells in combination with anti-angiogenic neoadjuvant therapy for advanced epithelial ovarian cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• METR-NK

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING